⌘K

Login Start Free

Home/Filings/4/0001209191-22-022495

4//SEC Filing

TAHL CINDY 4

Accession 0001209191-22-022495

CIK 0001434316other

View on SEC.gov Company Profile

Filed

Apr 3, 8:00 PM ET

Accepted

Apr 4, 5:01 PM ET

Size

12.4 KB

Accession

0001209191-22-022495

Insider Transaction Report

Form 4

Period: 2021-04-01

FATE THERAPEUTICS INCFATE

See Remarks

Transactions

Exercise/Conversion
Common Stock
2022-04-01$4.84/sh+19,433$94,056→ 208,584 total
Exercise/Conversion
Stock Option (Right to Buy)
2022-04-01−19,433→ 8,195 total
Exercise: $4.84Exp: 2025-01-05→ Common Stock (19,433 underlying)
Sale
Common Stock
2022-04-01$38.85/sh−25,000$971,250→ 189,151 total
Exercise/Conversion
Stock Option (Right to Buy)
2022-04-01−5,567→ 79,210 total
Exercise: $6.55Exp: 2028-01-16→ Common Stock (5,567 underlying)
Exercise/Conversion
Common Stock
2022-04-01$6.55/sh+5,567$36,464→ 214,151 total

Footnotes (2)

[F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 8, 2021.
[F2]This option is fully vested.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

FATE THERAPEUTICS INC

CIK 0001434316

Entity typeother

Related Parties

1

filerCIK 0001655472

Filing Metadata

Form type: 4
Filed: Apr 3, 8:00 PM ET
Accepted: Apr 4, 5:01 PM ET
Size: 12.4 KB

View on SEC.gov